Sagility India

Sagility reported an Adjusted EBITDA margin of 31.4% in Q3 FY25, significantly higher than its steady-state guidance of 24-25%. This expansion was primarily driven by the 'open enrollment' season in the US, where insurers add or renew members, leading to a surge in high-margin volumes. Management noted that while they added 1,215 employees to handle this surge, the operational efficiencies and technology investments made in previous quarters flowed directly to the bottom line. Additionally, a ₹300 million FX gain further bolstered the quarterly margin profile.

The acquisition of BroadPath Healthcare Solutions for $58 million marks a major step in Sagility's client diversification strategy. BroadPath brings over 30 mid-market clients and approximately $70 million in annual revenue, increasing Sagility's presence in the top 10 US payers from five to six. Although BroadPath currently operates at low double-digit EBITDA margins due to its onshore-heavy delivery model, Sagility plans to expand these margins by 600-700 basis points over the next 2-3 years through offshoring and administrative synergies.

While the Payer vertical remains the dominant revenue contributor at 89.3%, the Provider business grew at a much faster rate of 38% YoY in Q3. Management attributed this to a smaller base and a conscious strategy to penetrate deeper into the provider segment. Unlike the Payer business, the Provider segment does not see significant benefits from the open enrollment season, indicating that its growth is driven by structural demand for healthcare services and operational excellence.

Sagility demonstrated robust cash flow generation, with operating cash flow of ₹9,132 million in the first nine months representing 94% of reported EBITDA. This strong cash position allowed the company to fund the BroadPath acquisition entirely through internal accruals. Furthermore, the company has consistently reduced its debt, with net debt (including lease liabilities) now standing at a healthy 0.55x of trailing 12-month EBITDA, which management expects will continue to enhance PAT margins through lower interest costs.

Management addressed concerns regarding the new US administration and potential healthcare policy shifts. While acknowledging that healthcare is a highly regulated sector, they emphasized that labor shortages for clinicians and administrative staff in the US continue to drive the 'propensity to outsource.' They believe that even under cost pressure, clients are likely to move more work to partners like Sagility to achieve 30-60% savings compared to in-house operations. The company remains in a 'wait and watch' mode regarding specific policy changes like those from the Department of Government Efficiency (DOGE).